Evidence map›Paper›PMID 38076348›Full record

ArticleInternational journal of cardiology. Heart & vasculature2023

Clinical outcomes and predictors of long-term mortality, hemorrhagic and thromboembolic events in atrial fibrillation patients at different stages of chronic kidney disease: The CRAFT trial.

Marek Styczkiewicz, Mateusz Wawrzeńczyk, Michał Peller, Bartosz Krzowski, Cezary Maciejewski, Piotr Lodziński, Leszek Kraj, Grzegorz Opolski, Marcin Grabowski, Paweł Balsam

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02987062 (CRAFT - Multicenter Experience in Atrial Fibrillation Patients Treated With OAC), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02987062 unknown statusnot on this map

CRAFT - Multicenter Experience in Atrial Fibrillation Patients Treated With OAC (CRAFT)

TypeobservationalSponsorMedical University of WarsawRan2016 to 2017Enrolled2,000ConditionsAtrial Fibrillation
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Recent highlights from theInternational journal of cardiology. Heart & vasculature · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Marek StyczkiewiczDepartment of Cardiology, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland.
Mateusz Wawrzeńczyk1st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Michał Peller1st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Bartosz Krzowski1st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Cezary Maciejewski1st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Piotr Lodziński1st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Leszek KrajDepartment of Oncology, Medical University of Warsaw, Poland.
Grzegorz Opolski1st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Marcin Grabowski1st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Paweł Balsam1st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Medical University of Warsaw · PLJohn Paul II Hospital · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Chronic kidney disease (CKD) coexisting with atrial fibrillation (AF) increases the risk of hemorrhage and ischemia. The study aimed to determine the relationship between different CKD stages and clinical outcomes of patients suffering from both CKD and AF and to determine the predictors of outcome. Methods The data was derived from multicenter CRAFT trial (NCT02987062). We have conducted a retrospective analysis of hospital records of 2663 AF patients divided in three groups according to their estimated glomerular filtration rate (eGFR) which was <30ml/min/1,73 m2 for group I (n=63), ≥30 and <60 ml/min/1,73 m

Indexed as

Atrial fibrillationBleedingChronic kidney diseaseIschemiaSurvival

Identifiers

PMID38076348
PMCPMC10700826
OpenAlexW4388842179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.